About UCSF Search UCSF UCSF Medical Center

Lydia B. Zablotska, MD, MPA, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
zablotska_lydia

Assistant Professor, Department of Epidemiology and Biostatistics, UCSF

lydia.zablotska@ucsf.edu

Phone: (415) 476-4673 (voice)
UCSF Box 1229
San Francisco, CA 94143-1228

View on UCSF Profiles


Education

Minsk State Medical School, Belarus, MD, May 1993, Medicine
Askew School of Public Administration, Florida State University, MPA, August 1997, Public Policy and Health Administration/Policy
Mailman School of Public Health, Columbia University, PhD, May 2003, Epidemiology

Professional Experience

  • 1993-1995
    National Medical Residency, Internal Medicine, Lviv State Medical School, Ukraine
  • 1996
    Administrative and Research Internship, Center for Clinical Effectiveness, Ford Health System
  • 1997-2000
    Graduate Research Assistant, Project "Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia," Dr. G. Howe (PI), Department of Epidemiology, MSPH, Columbia University
  • 2000-2003
    Staff Associate, Project "Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia," Dr. G. Howe (PI), Department of Epidemiology, MSPH, Columbia University
  • 2003-2006
    Epidemiologist, Project "Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia," Dr. G. Howe (PI), Department of Epidemiology, MSPH, Columbia University
  • 2003-2004
    Instructor, Department of Epidemiology, Dr. E.Susser (Chairman), MSPH, Columbia University
  • 2004-2005
    Assistant Professor of Clinical Epidemiology, Department of Epidemiology, Dr. E.Susser (Chairman), MSPH, Columbia University
  • 2005-2008
    Assistant Professor of Epidemiology, Department of Epidemiology, Dr. E.Susser (Chairman), MSPH, Columbia University
  • 2008-present
    Assistant Professor, Department of Epidemiology and Biostatistics, Dr. R. Hiatt (Chairman), School of Medicine, University of California San Francisco

Honors & Awards

  • 1993
    Graduation with Distinction (Summa Cum Laude), Minsk State Medical School, Minsk, Belarus
  • 1995
    Senator E. Muskie Scholarship for Graduate Studies for Outstanding Students from the Commonwealth of Independent States, U.S. Agency for International Development
  • 2003
    Sydney Kark Award in Epidemiology for doctoral students committed to work in international health, MSPH, Columbia University
  • 2003
    Young Investigator Award, 12th International Congress of Radiation Research, Brisbane, Australia
  • 2004
    Calderone Junior Faculty Research Prize, MSPH, Columbia University
  • 2005
    Dean's Award for Innovation in the Curriculum, MSPH, Columbia University
  • 2006
    New Investigator's Award, American Statistical Association's Conference on Radiation and Health, Monterey Beach, CA
  • 2006
    Item Writing Committee, National Board of Public Health Examiners
  • 2007
    Young Investigator Award, 13th International Congress of Radiation Research, San Francisco, CA
  • 2007
    Invited Participant, Centers for Disease Control and Prevention (CDC) Workshop on Monoclonal B-cell Lymphocytosis and Chronic Lymphocytic Leukemia: Etiologic Factors, Precursors, and Disease, Washington, DC
  • 2008
    Invited Speaker, American Statistical Association's Conference on Radiation and Health, Vail, CO

Selected Publications

  1. Zablotska LB, Lane RS, Frost SE, Thompson PA. Leukemia, lymphoma and multiple myeloma mortality (1950-1999) and incidence (1969-1999) in the Eldorado uranium workers cohort. Environ Res. 2014 Feb 27; 130C:43-50.
    View on PubMed
  2. Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, Nadyrov E, Petrenko S, Romanov G, Yauseyenka V, Drozdovitch V, Minenko V, Prokopovich A, Savasteeva I, Zablotska LB, Mabuchi K, Brenner AV. Iodine-131 and thyroid function: ostroumova et Al. Respond. Environ Health Perspect. 2014 Feb 1; 122(2):A40-1.
    View on PubMed
  3. Little MP, Kukush AG, Masiuk SV, Shklyar S, Carroll RJ, Lubin JH, Kwon D, Brenner AV, Tronko MD, Mabuchi K, Bogdanova TI, Hatch M, Zablotska LB, Tereshchenko VP, Ostroumova E, Bouville AC, Drozdovitch V, Chepurny MI, Kovgan LN, Simon SL, Shpak VM, Likhtarev IA. Impact of Uncertainties in Exposure Assessment on Estimates of Thyroid Cancer Risk among Ukrainian Children and Adolescents Exposed from the Chernobyl Accident. PLoS One. 2014; 9(1):e85723.
    View on PubMed
  4. Zablotska LB, Lane RS, Thompson PA. A reanalysis of cancer mortality in Canadian nuclear workers (1956-1994) based on revised exposure and cohort data. Br J Cancer. 2014 Jan 7; 110(1):214-23.
    View on PubMed
  5. Zablotska LB, Little MP, Cornett RJ. Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the canadian fluoroscopy cohort study. Am J Epidemiol. 2014 Jan 1; 179(1):120-31.
    View on PubMed
  6. Little MP, Zablotska LB, Lipshultz SE. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med. 2013 Jun 27; 368(26):2523-4.
    View on PubMed
  7. Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, Nadyrov E, Petrenko S, Romanov G, Yauseyenka V, Drozdovitch V, Minenko V, Prokopovich A, Savasteeva I, Zablotska LB, Mabuchi K, Brenner AV. Measures of thyroid function among Belarusian children and adolescents exposed to iodine-131 from the accident at the chernobyl nuclear plant. Environ Health Perspect. 2013 Jul; 121(7):865-71.
    View on PubMed
  8. Zablotska LB, Lane RS, Frost SE. Mortality (1950-1999) and cancer incidence (1969-1999) of workers in the Port Hope cohort study exposed to a unique combination of radium, uranium and ?-ray doses. BMJ Open. 2013; 3(2).
    View on PubMed
  9. Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, Harrison JD, Hildebrandt G, Ivanov V, Kashcheev VV, Klymenko SV, Laurent O, Ozasa K, Tapio S, Taylor AM, Tzoulaki I, Vandoolaeghe WL, Wakeford R, Zablotska L, Zhang W, Lipshultz SE. Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Sch├Âllnberger et al. Radiat Environ Biophys. 2013 Mar; 52(1):157-9.
    View on PubMed
  10. Zablotska LB, Bazyka D, Lubin JH, Gudzenko N, Little MP, Hatch M, Finch S, Dyagil I, Reiss RF, Chumak VV, Bouville A, Drozdovitch V, Kryuchkov VP, Golovanov I, Bakhanova E, Babkina N, Lubarets T, Bebeshko V, Romanenko A, Mabuchi K. Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Environ Health Perspect. 2013 Jan; 121(1):59-65.
    View on PubMed
  11. Eidem├╝ller M, Jacob P, Lane RS, Frost SE, Zablotska LB. Lung cancer mortality (1950-1999) among Eldorado uranium workers: a comparison of models of carcinogenesis and empirical excess risk models. PLoS One. 2012; 7(8):e41431.
    View on PubMed
  12. Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, Harrison JD, Hildebrandt G, Ivanov V, Kashcheev VV, Klymenko SV, Kreuzer M, Laurent O, Ozasa K, Schneider T, Tapio S, Taylor AM, Tzoulaki I, Vandoolaeghe WL, Wakeford R, Zablotska LB, Zhang W, Lipshultz SE. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect. 2012 Nov; 120(11):1503-11.
    View on PubMed
  13. Tronko M, Mabuchi K, Bogdanova T, Hatch M, Likhtarev I, Bouville A, Oliynik V, McConnell R, Shpak V, Zablotska L, Tereshchenko V, Brenner A, Zamotayeva G. Thyroid cancer in Ukraine after the Chernobyl accident (in the framework of the Ukraine-US Thyroid Project). J Radiol Prot. 2012 Mar; 32(1):N65-9.
    View on PubMed
  14. Hatch M, Polyanskaya O, McConnell R, Gong Z, Drozdovitch V, Rozhko A, Prokopovich A, Petrenko S, Brenner A, Zablotska L. Urinary Iodine and Goiter Prevalence in Belarus: experience of the Belarus-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl nuclear accident. Thyroid. 2011 Apr; 21(4):429-37.
    View on PubMed
  15. Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, Lubin JH, Zablotska LB, Tereschenko VP, McConnell RJ, Zamotaeva GA, O'Kane P, Bouville AC, Chaykovskaya LV, Greenebaum E, Paster IP, Shpak VM, Ron E. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect. 2011 Jul; 119(7):933-9.
    View on PubMed
  16. Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, Brenner AV, Lubin J, Romanov GN, McConnell RJ, O'Kane P, Evseenko VV, Drozdovitch VV, Luckyanov N, Minenko VF, Bouville A, Masyakin VB. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer. 2011 Jan 4; 104(1):181-7.
    View on PubMed
  17. Zablotska LB, Gong Z, Wang F, Holly EA, Bracci PM. Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control. 2011 Jan; 22(1):91-100.
    View on PubMed
  18. Hatch M, Furukawa K, Brenner A, Olinjyk V, Ron E, Zablotska L, Terekhova G, McConnell R, Markov V, Shpak V, Ostroumova E, Bouville A, Tronko M. Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res. 2010 Dec; 174(6):763-72.
    View on PubMed
  19. Hatch M, Furukawa K, Brenner A, Olinjyk V, Ron E, Zablotska L, Terekhova G, McConnell R, Markov V, Shpak V, Ostroumova E, Bouville A, Tronko M. Prevalence of Hyperthyroidism after Exposure during Childhood or Adolescence to Radioiodines from the Chornobyl Nuclear Accident: Dose–Response Results from the Ukrainian-American Cohort Study. Radiat Res. 2010 Oct 7.
    View on PubMed
  20. Lane RS, Frost SE, Howe GR, Zablotska LB. Mortality (1950-1999) and cancer incidence (1969-1999) in the cohort of Eldorado uranium workers. Radiat Res. 2010 Dec; 174(6):773-85.
    View on PubMed

Go to UCSF Profiles, powered by CTSI